The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases
Open accessAbstract
Tumor necrosis factor (TNF) is key to the pathogenesis of various arthritic diseases and inflammatory bowel disease (IBD). Anti-TNF therapies have proved successful in the clinical treatment of these diseases, but a mechanistic understanding of TNF function is still lacking. We have investigated early cellular mechanisms of TNF function in these diseases using an established TNF transgenic model, which develops a spondyloarthritis-like disease characterized by peripheral joint arthritis, sacroiliitis, enthesitis, and Crohn's-like IBD. Bone marrow grafting experiments demonstrated that development of arthritis requires TNF receptor I (TNFRI) expression in the radiation-resistant compartment, which is also known to be a sufficient target of TNF in the development of Crohn's-like IBD in the same model. Early activation of synovial fibroblasts and intestinal myofibroblasts could also be demonstrated by perturbed expression of matrix metalloproteases and their inhibitors. Notably, selective Cre/loxP-mediated TNFRI expression in mesenchymal cells resulted in a fully arthritic–spondyloarthritic and intestinal phenotype, indicating that mesenchymal cells are primary and sufficient targets of TNF in these pathologies. Our results offer a novel mechanistic perspective for TNF function in gut and joint pathologies and indicate early common cellular pathways that may also explain the often observed synovial–gut axis in human disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., & Mak, T. W. (1993) · Cell · doi:10.1016/0092-8674(93)90134-c · Cited by 1,677
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Self-citationImpaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements
Kontoyiannis, D., Pasparakis, M., Pizarro, T. T., Cominelli, F., & Kollias, G. (1999) · Immunity · doi:10.1016/s1074-7613(00)80038-2 · Cited by 1,344
Self-citationEpithelial NEMO links innate immunity to chronic intestinal inflammation
Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth, M., Nikolaev, A., Neufert, C., Madison, B., et al. (2007) · Nature · doi:10.1038/nature05698 · Cited by 1,077
Hammer, R. E., Maika, S. D., Richardson, J. A., Tang, J.-P., & Taurog, J. D. (1990) · Cell · doi:10.1016/0092-8674(90)90512-d · Cited by 1,005
Novak, A., Guo, C., Yang, W., Nagy, A., & Lobe, C. G. (2000) · genesis · doi:10.1002/1526-968x(200011/12)28:3/4<147::aid-gene90>3.0.co;2-g · Cited by 844
Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation
Buckley, C. D., Pilling, D., Lord, J. M., Akbar, A. N., Scheel-Toellner, D., & Salmon, M. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01863-4 · Cited by 796
Müller‐Ladner, U., Kriegsmann, J., Franklin, B. N., Matsumoto, S., Geiler, T., Gay, R. E., & Gay, S. (1996) · Europe PMC (PubMed Central) · Cited by 606
Myofibroblasts. II. Intestinal subepithelial myofibroblasts
Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., & West, A. B. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.2.c183 · Cited by 566
Update on Spondyloarthropathies
Khan, M. A. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-12-200206180-00011 · Cited by 517
Design of effective immunotherapy for human autoimmunity
Feldmann, M., & Steinman, L. (2005) · Nature · doi:10.1038/nature03727 · Cited by 277
Kontoyiannis, D., Boulougouris, G., Manoloukos, M., Armaka, M., Apostolaki, M., Pizarro, T., Kotlyarov, A., Forster, I., Flavell, R., Gaestel, M., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020281 · Cited by 266
Self-citationThe evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects.
Mielants, H., VEYS, E. M., De Vos, M., et al. (1995) · PubMed · Cited by 261
Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association.
K, D. V., Mielants, H., Cuvelier, C. A., De Keyser, F., Veys, E. M., & De Vos, M. (2000) · PubMed · Cited by 247
Biologic therapies in rheumatology: lessons learned, future directions
Strand, V., Kimberly, R., & Isaacs, J. D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2196 · Cited by 216
Firestein, G. S., & Zvaifler, N. J. (2002) · Arthritis & Rheumatism · doi:10.1002/art.502 · Cited by 214
Evolving knowledge and therapy of inflammatory bowel disease
Korzenik, J. R., & Podolsky, D. K. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1986 · Cited by 208
Ileocolonoscopic Findings in Seronegative Spondylarthropathies
Mielants, H., Veys, E. M., Cuvelier, C., & de Vos, M. (1988) · Rheumatology · doi:10.1093/rheumatology/xxvii.suppl_2.95 · Cited by 184
Salmi, M., Andrew, D. P., Butcher, E. C., & Jalkanen, S. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.1.137 · Cited by 139
Bailey, C. J., Hembry, R. M., Alexander, A., et al. (1994) · Journal of Clinical Pathology · doi:10.1136/jcp.47.2.113 · Cited by 136
Pender, S. L. F., Fell, J. M. E., Chamow, S. M., Ashkenazi, A., & MacDonald, T. T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.4098 · Cited by 123
Victoratos, P., Lagnel, J., Tzima, S., Alimzhanov, M. B., Rajewsky, K., Pasparakis, M., & Kollias, G. A. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.013 · Cited by 123
Self-citationSubepithelial Myofibroblasts are Novel Nonprofessional APCs in the Human Colonic Mucosa
Saada, J. I., Pinchuk, I. V., Barrera, C. A., Adegboyega, P. A., Suárez, G., Mifflin, R. C., Mari, J. F. D., Reyes, V. E., & Powell, D. W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5968 · Cited by 116
Matrix metalloproteinases and the gut — new roles for old enzymes
Pender, S. L. F., & MacDonald, T. T. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.06.005 · Cited by 89
Braghetta, P., Fabbro, C., Piccolo, S., Marvulli, D., Bonaldo, P., Volpin, D., & Bressan, G. M. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.135.4.1163 · Cited by 41
Cited by
Kaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806
Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes
Nygaard, G., & Firestein, G. S. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0413-5 · Cited by 928
The Australo-Anglo-American Spondyloarthritis Consortium (TASC), Evans, D. M., the Wellcome Trust Case Control Consortium 2 (WTCCC2), Spondyloarthritis Research Consortium of Canada (SPARCC), Spencer, C. C. A., Pointon, J. J., Su, Z., Harvey, D., Kochan, G., Oppermann, U., et al. (2011) · Nature Genetics · doi:10.1038/ng.873 · Cited by 893
Dougados, M., & Baeten, D. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60071-8 · Cited by 780
Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease
Friedrich, M., Pohin, M., & Powrie, F. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.017 · Cited by 750
Metadata
- Authors
- Armaka, M., Apostolaki, M., Jacques, P., Kontoyiannis, D. L., Elewaut, D., & Kollias, G.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2008-02-04
- Volume
- 205
- Issue
- 2
- Pages
- 331-337
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2105738742
- Cited by
- 370
- References
- 27
- FWCI
- 13.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.